Does USTEKINUMAB Cause Product dose omission issue? 9,405 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9,405 reports of Product dose omission issue have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 11.0% of all adverse event reports for USTEKINUMAB.
9,405
Reports of Product dose omission issue with USTEKINUMAB
11.0%
of all USTEKINUMAB reports
5
Deaths
214
Hospitalizations
How Dangerous Is Product dose omission issue From USTEKINUMAB?
Of the 9,405 reports, 5 (0.1%) resulted in death, 214 (2.3%) required hospitalization, and 15 (0.2%) were considered life-threatening.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 9,405 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Off label use (10,990)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
Infusion related reaction (4,471)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
GOLIMUMAB (4,216)
Which USTEKINUMAB Alternatives Have Lower Product dose omission issue Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE